Read + Share
Tunney MM, Wark P. Long-term therapy with elexacaftor/tezacaftor/ivacaftor (ETI) in cystic fibrosis:
improved clinical outcomes but infection and inflammation persist. Eur Respir J 2023;62:2301008.
PMID: 37536727
|
 |
|
Tunney MM, Wark P. Long-term therapy with elexacaftor/tezacaftor/ivacaftor (ETI) in cystic fibrosis:
improved clinical outcomes but infection and inflammation persist. Eur Respir J 2023;62:2301008.
PMID: 37536727
|
|
|
|